PBL Licenses Erwinase® to Clinigen Home News PBL Licenses Erwinase® to Clinigen PBL sign exclusive contract Porton Biopharma Limited (“PBL”), the UK biopharmaceutical research, development and manufacturing company, announces that it has signed an exclusive, worldwide licensing agreement with Clinigen Group plc (“Clinigen”) for the distribution of Erwinase®/ Erwinaze® (“Erwinase”), the Company’s life-saving treatment for acute lymphoblastic leukaemia, a cancer of the blood predominantly affecting children. Clinigen is a UK-based healthcare business with an international distribution network, a focus on cancer and a particular ability to match products and patients. This new relationship with Clinigen offers significant long-term financial and commercial benefits for PBL, enabling the Company to grow and further the supply of Erwinase. PBL will receive future sales-based milestone payments, alongside tiered royalty payments based upon worldwide net sales. The agreement represents an attractive return for PBL and its sole shareholder, the UK Government’s Department of Health and Social Care. The new contract with Clinigen will begin on January 1st 2021. For more information see the Clinigen press release. Erwinase® available for UK orders-Supply update Get in touch Porton Biopharma Limited, Manor Farm Road, Porton Down, Salisbury, Wiltshire, SP4 0JG +44 (0)1980 612100 business@portonbiopharma.com Follow our journey: About us About Products What we do News Contact Careers Career Opportunities Recruitment Process Why join us… Working at… Staff Stories Legal Anti-slavery policy Animal policy Gender Pay Freedom of Information Terms of Use Acceptable Use Policy © 2021 Porton BiopharmaWebsite by blue beeTerms of Use Privacy Policy Cookie Policy Registered in England and Wales, company number 9331560. Registered office at Manor Farm Road, Porton Down, Salisbury, Wiltshire SP4 0JG. VAT number is GB 206 6518 18. This website uses cookies By using our website you consent to all cookies in accordance with our Cookie Policy. Read more STRICTLY NECESSARY PERFORMANCE ACCEPT ALL DECLINE ALL SHOW DETAILS